Next Article in Journal
Knobs, Adhesion, and Severe Falciparum Malaria
Previous Article in Journal
Assessing the Relationship between Annual Surface Temperature Changes and the Burden of Dengue: Implications for Climate Change and Global Health Outcomes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Modelling Differential Diagnosis of Febrile Diseases with Fuzzy Cognitive Map

1
Department of Computer Science, University of Uyo, Uyo 520103, Nigeria
2
Department of Mathematics and Computer Science, Ritman University, Ikot Ekpene 530101, Nigeria
3
Health Systems Research Hub, University of Uyo Teaching Hospital, Uyo 520103, Nigeria
4
Department of Mathematics and Computing, Mount Royal University, Calgary, AB T3E 6K6, Canada
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2023, 8(7), 352; https://doi.org/10.3390/tropicalmed8070352
Submission received: 23 March 2023 / Revised: 26 May 2023 / Accepted: 28 June 2023 / Published: 3 July 2023
(This article belongs to the Section Infectious Diseases)

Abstract

:
The report of the World Health Organization (WHO) about the poor accessibility of people living in low-to-middle-income countries to medical facilities and personnel has been a concern to both professionals and nonprofessionals in healthcare. This poor accessibility has led to high morbidity and mortality rates in tropical regions, especially when such a disease presents itself with confusable symptoms that are not easily differentiable by inexperienced doctors, such as those found in febrile diseases. This prompted the development of the fuzzy cognitive map (FCM) model to serve as a decision-support tool for medical health workers in the diagnosis of febrile diseases. With 2465 datasets gathered from four states in the febrile diseases-prone regions in Nigeria with the aid of 60 medical doctors, 10 of those doctors helped in weighting and fuzzifying the symptoms, which were used to generate the FCM model. Results obtained from computations to predict diagnosis results for the 2465 patients, and those diagnosed by the physicians on the field, showed an average of 87% accuracy for the 11 febrile diseases used in the study. The number of comorbidities of diseases with varying degrees of severity for most patients in the study also covary strongly with those found by the physicians in the field.

1. Introduction

The signs and symptoms of a disease distinguish one disease from another. Sometimes, these signs and symptoms are so similar that it becomes a challenge to make a fast and accurate distinction and this could result in an inaccurate diagnosis. Since diagnosis is the bedrock of medical practice [1], an inaccurate diagnosis could lead to complications, and, if not handled properly, could lead to the death of the victim [2]. Febrile diseases are fever-based diseases with similar and overlapping symptoms that are often confusable and difficult to differentiate. They are prevalent in tropical and subtropical regions where climatic conditions such as temperature, humidity, and evaporation contribute immensely to promoting the spread. According to Attai et al. [3], tropical locations around the world are severely affected by infectious diseases.
The knowledge of the symptoms, the etiology of a disease, and the thought process gained during practice help a physician to associate symptoms with a disease. The cognitive mapping operations could be transferred into a machine for more accurate and faster processing than a human physician does. Among many other challenges, the traditional logic of a computer does not support human reasoning as it exhibits exactness in its methodology [4]. This shortcoming of conventional logic becomes more pronounced in medical diagnosis because of ambiguities associated with a patient’s medical history, laboratory investigation results, symptom elicitation, etc.
The limitation of conventional logic is overcome with fuzzy logic technology capable of resolving ambiguities and uncertainties through collaboration and aggregation and reasoning with approximation as done by the human physician [5]. With fuzzy logic, transferring the knowledge of the human physician becomes easier as the cognition operation can be mapped with fuzzified datasets and later defuzzified into crisp outputs.
Physicians are prone to errors, and medical diagnostics errors could be life threatening [2]. The errors could be because of a lack of experience, the large volume of data due to an influx of patients requiring services from a limited number of physicians, poor accessibility to patients’ previous records to obtain medical history, the inability of patients to express their feelings of a particular symptom, among other reasons. They (physicians), therefore, need a tool that can assist them in reducing these errors. One such tool is the medical decision support system (MDSS), which has been useful in making critical decisions.
One of the main reasons the population, particularly those in tropical regions, cannot get medical care, according to the World Health Organization (WHO), is a lack of medical personnel. According to Mehta et al. [6], African healthcare facilities are vastly understaffed and under-resourced. The WHO [7] report of the 2018 accessibility to medical personnel in Africa is appalling, as the density ratio of 5000 patients is equated to 1 physician and 6 nurses. These statistics justify the need for a decision-support diagnostic tool to aid in curbing the rising cases of mortality caused by, among other factors, the lack of access to medical facilities by an average person living in tropical regions, especially in rural settings and resource-scarce areas.
The study aims at developing an FCM-based MDSS for febrile diseases to solve the problems of (i) poor access to medical care for febrile diseases patients in low-to-middle-income countries and resource-scarce areas and (ii) poor differentiation of signs and symptoms of febrile diseases by inexperienced physicians. The objectives of the study are to (a) gather datasets from patients of febrile diseases in four states in Nigeria where febrile diseases are prevalent, (b) obtain experiential knowledge of medical doctors who specialize in febrile diseases, (c) develop an FCM-based model for the differential diagnosis of 11 febrile diseases, (d) analyze the results obtained from the developed system and compare with the results of the domain experts, and (e) evaluate the number of comorbidity of diseases. The uniqueness of this study is in (i) the method of generating weights for the adjacency matrix, (ii) the inclusion of a decision filter to capture the emotional feelings of the patients to form part of the decision variables, and (iii) the evaluation of comorbidity of diseases, which is known to be one of the causes of mortality because of inadequate attention given to patients in the course of diagnosis.
The rest of the paper is organized as follows; Section 2 presents the related literature while Section 3 presents the methodology of carrying out the research. The results of the experiment carried out are presented and analysed in Section 4. Recommendations made and conclusions drawn are presented in Section 5.

2. Related Literature

A disease associated with fever is commonly referred to as a febrile disease. Prasad et al. [8] demonstrated a wide range of pathogens associated with several febrile diseases. However, the distribution of the disease varies by geography, season, age, and immunity of the patient. According to Bell [9], the relative frequency of acute febrile syndrome varies widely with geography, living condition, and occupational exposure. There has been some research on the differential diagnosis of confusable symptoms of febrile diseases. Malaria tends to become the default diagnosis of febrile diseases due to its ubiquity and severity [10,11], such that if a patient presenting the symptoms is tested for malaria and the result is found to be negative, such a patient is left untreated for other diseases by an inexperienced medical doctor with the risk of complications. According to Crump et al. [12], healthcare workers often lack epidemiological information or the laboratory services necessary to support rational diagnostic and management decisions for patients with negative malaria diagnostic test results.
In order to treat a nonmalaria febrile illness properly (keeping in mind that patients may have malaria concurrently with another disease, especially in high endemic areas), the pathogens that cause a febrile disease must be known. If the agent is not identified, knowing the category of the pathogen (parasitic, bacterial, or viral) is useful for deciding on treatment [13]. This requires high-level accuracy of differentiation of the symptoms. Patients with enteric fever develop problems and may require therapy with longer antibi-otics to remove the infection. Enteric fever symptoms include fever, diarrhoea, muscle aches, stomach pain, rash, and others; therefore, certain guidelines are important to assist clinicians in performing the right tests and treating patients with enteric fever [14]. The ability to detect Mycobacterium tuberculosis (MTB) infection, recognize the factors that lead to tuberculosis (TB) disease, receive preventative therapy, and put methods in place to track infections and treatment completion all contribute to better control of tuberculosis [15]. Dengue fever is the most prevalent viral illness spread by mosquitoes; although it is typically moderate, dengue fever can progress into a severe type that can be fatal [16].
A review by the WHO [17] on the different tools used to evaluate acute febrile illness (AFI) in South India shows malaria to be the commonest cause of AFI, followed by dengue, scrub typhus, bacteremia, and leptospirosis. It was also revealed that malaria diagnosed by smear microscopy was more popular than other methods of tests.
Considerable research is undertaken on the alternative diagnostic methods for malaria, tuberculosis, HIV/AIDS, and dengue fever, leaving the other febrile diseases almost neglected. The effect of this is positively felt in malaria, where there was about a 40% reduction in the incidence of malaria between 2000 and 2015 [7]. A significant challenge is the acute shortage of physicians in febrile disease-prone areas. The WHO [7] gave the 2018 report on accessibility to medical personnel in Africa. According to the report, the density ratio of a physician to a 5000 populace is 1, while that of nurses/midwives is 6. This poor accessibility has affected the proper diagnosis and treatment of febrile diseases, thereby increasing the morbidity and mortality rate. The experts have a great role to play in developing systems capable of retaining knowledge and assisting them in their jobs. The medical decision support system (MDSS) has been found useful to medical practitioners in an attempt to increase the accessibility of patients to medical care and reduce the workload of personnel.
Although several approaches are used to enhance processes of improving individual health, the introduction of the fuzzy logic approach seems more human-like because of its ability to deal with uncertainty and ambiguity, which are recurring attributes in medical records. Das et al. [18] adopted fuzzy logic to model doctors’/medical experts’ confidence levels in diagnosing diseases in the patient. Their method is composed of the following four steps: (i) the modelling of the antecedent part of the rules, which consists of linguistic assessments of the patient’s symptoms provided by the doctors/medical experts with their corresponding confidence levels by using generalized fuzzy numbers; (ii) the modelling of a consequent part, which reveals the degree of association and the degree of non-association of diseases into the patient, by using intuitionistic fuzzy system (IFS); (iii) the use of an IFS aggregation operator in the inference process; and (iv) the application of a relative closeness function to find the final crisp output for a given diagnosis. Nilashi et al. [19] proposed a knowledge-based system for breast-cancer classification using fuzzy logic to assist medical practitioners in their clinical decision support towards their healthcare practice. The proposed knowledge-based system proves to have a better prediction accuracy (0.932) for breast cancer in relation to PCA-SVM (0.867), PCA-KNN (0.823), and decision tree (0.929).
Amjad et al. [20] employed an expert soft sets system (SES) based on the soft sets and the fuzzy set theory to diagnose dengue fever. They calculated the risk percentage of 30 patients with the help of soft sets, and it was noted that 13 patients were suffering from dengue while the other 17 patients had no complaints of dengue fever. Sharma et al. [21] introduced the concept of mediative fuzzy relation between the conventional fuzzy set and the intuitionistic fuzzy set. The mediative fuzzy projection was used in the diagnosis of COVID-19 in post-COVID-19 patients. The results obtained from the study were compared with that of conventional and intuitionist fuzzy projection and found to covary strongly. Magwili et al. [22] provided a preliminary diagnosis for patients suffering from mosquito-borne diseases by comparing the system’s preliminary diagnosis with the expert’s diagnosis in a total of 80 tests with 20 tests per disease; 71.67%, 83.33%, and 91.67% of the time, the system correctly prediagnosed dengue, chikungunya, and malaria, respectively. For other diseases, the system correctly identified the unlikelihood of having the said mosquito-borne diseases 91.67% of the time. Moreover, a chi-square test was also conducted with a level of significance of 0.05, yielding a p-value of 0.464. According to Putra and Prihatini [23], tropical infectious diseases require appropriate treatment with the active participation of a doctor and patients. In their result for defuzzification, they calculated the sequential and combined certainty factor, which represents the belief percentage of disease diagnosis suffered by the patient. The results of the expert diagnosis with the expert system for the given cases indicate the system has similarity diagnosis with the expert at 93.99%.
Ekong et al. [24] demonstrated that information technology and medicine could successfully operate together using differential diagnosis by applying fuzzy logic to medical informatics. The result increased productivity in the grid system by an average of 20%. They suggested the need to apply fuzzy logic because it will help to resolve conflicts that may arise from ambiguity, uncertainty, and imprecision in the investigation of tropical diseases. A fuzzy cognitive map (FCM) is a technique for realizing an efficient MDSS. It is built based on the experience of the domain experts who provide the degree of influence and causal knowledge of one concept to another. This means it relies on what an expert, such as a physician, perceives as the causal relationship of a symptom, such as a headache, to a disease such as malaria. This degree of influence is captured and represented as a link between headaches and malaria. According to Bourgani et al. [25], a fuzzy cognitive map is a soft computing technique used for causal knowledge acquisition and supporting the causal knowledge reasoning process. The FCM modelling approach resembles human reasoning; it relies on the human’s expert knowledge of a domain, making associations along generalized relationships between domain descriptors. Bourgani showed different forms of FCM structures for MDSS, made comparisons, and recommended temporal concepts to be included in the design of MDSS for dynamism and efficiency.
Amirkhani et al. [26] identified the different FCM structures used in MDSS after a thorough analysis of each structure and reviewed various diagnoses and decision-support problems addressed by FCMs to determine their contributions to improving medical diagnosis and treatment. Groumpos [27] explored the concept of causality to model a new state space, advanced fuzzy cognitive map (AFCM) methodology for modelling COVID-19 diagnosis. He noted that correlation does not imply causality while causality always implies correlation. He found that the FCM theories are probably the only ones that explore the causality between the variables of medical problems in a sound mathematical and scientific foundation. In Papageorgiou et al. [28] the diagnosis of the degree of severity of pulmonary infection using 33 symptoms of infectious diseases was carried out using the FCM technique. Hypothetical cases were used for the simulation of the results, showing the calculated severity of pulmonary infection to be above 90%. FCM Expert, a software for FCM modelling, was used to analyze a scenario and perform pattern classification [29].
Mpelogianni and Groumpos [30] modified the conventional FCM to obtain a mathematical model that uses a state-space approach to disaggregate the concepts into state concepts, input concepts, and output concepts. The model was then used to compute a building’s energy consumption and management of its loads. Results of computations when compared with that of the conventional FCM were found to be more accurate. According to Apostolopoulos and Groumpos [31], FCMs are potentially trustworthy because they incorporate human knowledge. Based on the parameters of trust, transparency, and causality, an explainable AI is proposed for FCM-based systems.
The architecture and features of the software were shown and discussed, including the characteristics, such as its ability to improve system convergence. A case study of FCM-based classification for modelling the resistance of HIV-1 mutations was demonstrated using a particle-swarm optimizer. A differential diagnosis of 6 eye diseases with 23 symptoms was undertaken by Obot et al. [32], where 2 independent opticians diagnosed 20 patients each and compared with the results of diagnosis using FCM with the Hebbian learning rule. The results show 65% and 45% accuracy for the first and second opticians’ diagnoses, respectively. Apostolopoulos et al. [33] developed a state space advanced FCM to detect Coronary Artery Disease (CAD). The state space concepts consist of the input concepts, the state concepts, and the output concepts, where the state concepts depict the concepts that describe the operations of the system. This was later embedded in diagnostic rules developed by cardiologists. A total of 303 patient datasets collected from the Department of Nuclear Medicine of Patras, in Greece, were used to train and test the developed system. The results, compared with the classical FCM, showed 85.47% accuracy, which is a 7% higher accuracy than the conventional method of diagnosis. Apostolopoulos and Groumpos [34] solved the problems of ambiguity and uncertainty in coronary artery disease diagnosis using the noninvasive method with FCM. The results obtained showed an accuracy of 78.2%, which were reported to be better than what was obtained from other algorithms.
A time unit proposed by Bourgani et al. [35] that can follow disease progression is introduced into FCM to develop a diagnostic tool for differential diagnosis of pulmonary diseases (acute bronchitis and common-acquired pneumonia). Time-based FCM was proposed here because the values of weights and concepts of such diseases change according to the time interval. Uzoka et al. [36] proposed a framework for differential diagnosis of tropical confusable diseases using a fuzzy cognitive-map engine where 11 symptoms of 7 diseases were found to be confusable. The study employed the experiential knowledge of practising physicians and utilized a brute-force algorithmic procedure to mimic the mental algorithm used by physicians in the diagnosis process. A case study of malaria was carried out with 20 datasets, of which 55% matched the physicians’ diagnoses, and 85% matched the FCM diagnoses. Uzoka et al. [37] showed a higher (though equally significant) correlation between the FCM results and actual diagnosis (AD), and between initial hypotheses (IH) and AD. The comparative summary showed that the IH by the physicians correctly matched the final diagnosis in 55% of the cases, whereas AD of the FCM was 85%. This also connotes that the correlation between the physician’s initial hypothesis and the FCM diagnosis was not significant.
Hoyos et al. [38] used fuzzy cognitive maps to enhance clinical decision-support systems for dengue fever. The developed model showed a good classification performance with 89.4% accuracy and could evaluate the behaviour of clinical and laboratory variables related to dengue severity (it is an explainable method). Their model serves as a diagnostic aid for dengue that could be used by medical professionals in clinical settings and [39] applied a fuzzy cognitive map for geospatial dengue outbreak-risk prediction in tropical regions of Southern India. The accuracy of the proposed FCM-based classification approach is much better than the benchmark machine-learning algorithms, which show a deficiency in working with small datasets and without being able to use experts’ knowledge.

3. Methodology

The study started with the process of collecting datasets from which they were fuzzified and analyzed to obtain weights of each symptom and their corresponding diseases. The weights obtained were validated by the medical team of the project and used to generate a weight matrix and a fuzzy cognitive map. The training was then carried out using the Hebbian learning rule on the sigmoidal activation function. The results obtained were analysed using the confusion matrix to perform binary classification. The flow chart in Figure 1 summarizes the steps employed in carrying out the research. Each of the steps is discussed subsequently.

3.1. Data Collection

Febrile disease datasets were collected through a field study in four (4) states in the Niger Delta region of Nigeria, comprising; Akwa Ibom, Cross River, Rivers, and Imo state. An Open Data Kit app [40] was used to collect the datasets based on two questionnaire instruments validated by domain experts (medical doctors). One data source extracted experiential knowledge from a random sample of sixty-two (62) physicians in the study area, in private and public health facilities, who have expertise in diagnosing febrile diseases. The second data source was gathered from a patient-consultation instrument designed to assist physicians in eliciting patients’ symptoms and recording preliminary diagnoses, including further investigations and final diagnoses outcomes. The second data source was employed in this research. Each symptom was rated on a scale of 1–6, representing absent, very low, low, moderate, high, and very high severity, respectively. The final diagnosis for each patient examined by the medical doctor was also rated on the same scale. In concluding the final diagnosis, the physicians also were cognizant of the risk factors associated with each of the eleven (11) febrile diseases considered in the study. These risk factors provide physicians with the opportunity to associate them (e.g., genetic conditions, high blood pressure, high cholesterol level, exposure to mosquito bites, and travel to endemic regions) with each disease under consideration on a numeric scale (1 = No effect, 2 = Weak effect, 3 = Moderate effect, 4 = Strong effect, 5 = Very strong effect).
The dataset used for the study contains 4879 patient records out of which 1617 were found to contain some missing fields so were removed. To preserve the dataset’s integrity, records with omitted symptoms or diseases were removed. After this, of the 3253 records left, 185 were found to be that of children below 5 years of age and the data collection instrument did not capture some of the symptoms presented by patients with tropical febrile conditions of this age range. The age at which a person transitions from childhood to adulthood may vary depending on the culture, and the legal definition often ranges from 16 to 21 years [41]. In this study, patient records above 16 years were selected. The records of those above 16 years numbering 2465 were therefore tagged as the adult datasets and used for this study.

3.2. Fuzzification of Datasets

The values in the datasets collected were crisps and needed to be fuzzified. This was done with the triangular membership function given by the formula.
F ( x ) = x 0.5 6
F ( x ) = { 0.0 < = x < = 0.1 ………………….. N o   D i s e a s e 0.1 < = x < = 0.4 ………………….. V e r y L o w 0.35 < = x < = 0.5 ………………… L o w 0.40 < = x < = 0.60 ………………. M o d e r a t e 0.55 < = x < = 0.80 ………………. H i g h 0.80 < = x < = 1.0 ………………… V e r y H i g h
The choice of the triangular membership function stems from the fact that the boundary between linguistic variables in the datasets is not so thin to warrant the use of other membership functions, such as trapezoidal or Gaussian. Again, a study by Princy and Dhenakara [42] shows that the triangular membership function gives better accuracy on medical datasets.

3.3. Weight of Symptoms

Based on the frequency of reported cases of a symptom on the entire datasets obtained, the Pearson, Kendall, and Spearman correlation tools were used to determine the correlation between each disease and the corresponding symptom. The average value of the three tools was obtained and used to rank the symptoms accordingly. Outliers were removed, and a threshold was determined by a team of 10 medical doctors after observing the value of each symptom and its rank. For example, 13 symptoms were identified as symptoms of malaria with their corresponding weights as shown in Table 1. Bitter taste in the mouth (BITAIM) was observed to rank first with a value of 0.52, followed by chill and rigour (CHLNRIG) with 0.39. Vomiting (VMT) was ranked last with a weight value of 0.19 and used as the threshold weight for malaria. The listing of the symptoms and their ranking results for other diseases are presented in Appendix A.
All these were combined to generate a weight matrix which was used to draw the fuzzy cognitive map, as shown in Figure 2.
The causal relationship between the symptoms of a particular disease and the disease is shown on a fuzzy cognitive map (FCM). A synergy is established amongst the eleven diseases identified as febrile due to their similarity in symptoms and the aetiology of the disease. The value attached between each of the symptoms and its corresponding disease represents the weight of the symptom to the disease and, therefore, its causal value. The concepts (symptoms and diseases) for the differential diagnosis of the eleven diseases are shown in Appendix B. There are 61 concepts comprising 50 class concepts (symptoms), labelled T1 to T50, and 11 decision concepts (diseases), labelled D1 to D11. The corresponding map (FCM) is shown in Figure 2.

3.4. The System Architecture

The components of the system interact with one another, as depicted in the architectural design in Figure 3, which comprises the medical experts, the frontline healthcare workers (FHWs), the patients, the knowledge base, the diagnostic engine, the FCM engine, the decision-support filters, and the graphic user interface as the main components. A patient’s signs, symptoms, and laboratory test results are captured into the knowledge base through the graphic user interface by the FHWs. This information is stored in the knowledge base of the system along with static and dynamic (experiential) knowledge of the medical experts for later use by the diagnostic engine of the system for processing. The risk factors and emotional feelings of a patient are captured through the decision support filters to the diagnostic engine. The knowledge base feeds the diagnostic engine, which first fuzzifies the datasets and then maps the corresponding signs and symptoms with the appropriate diseases. The computed values are thereafter defuzzified into crisp outputs and sent back to the FHWs as the diagnostic results.

3.5. FCM Computations

The value of each concept is influenced by the value of the connected concepts with the corresponding causal weights and their previous value. The value of concept represents the degree of severity of a particular symptom of a disease as assigned by the medical doctor during the diagnosis. The causal weights are generally agreed by the 10 medical doctors to be the causal effects or the degree of influence on the corresponding symptom. The model used for the computations is given as:
A i ( t + 1 ) = f ( A i ( t ) + j i , j = 1 ( A j ( t ) . E ji ) )
where A i ( t + 1 ) is the value of concept C i at step ( t + 1 ) ; A j ( t ) is the value of concept C j at step t , E ji is the weight of the interconnection from C j to C i , and f is the threshold function. A concept cannot be linked to itself, so j < > i (j is not equal to i), the subscripts (j and i) denote the position of the concept with i being the position of the source concept and j the position of the destination concept; for example, if fever is concept 5 (C5) and malaria is concept 51(C51), then i = 5, j = 51. A link between fever and malaria is Cij and the weight (value) is established between the link as the causal effect. In our map, T1–T50 represent C1–C50 and D1–D11 represent C51–C61. Each of the 61 concepts takes 6 fuzzy values of “no disease, very mild, mild, moderate, high, and very high” membership functions. In computing the final value that represents the diagnostic state of a patient, the initial vector that shows the state of health of a patient, as expressed by the physician that interrogated the patient, is multiplied by the weight matrix following Equation (3). The result is applied to the sigmoidal continuous function to obtain the final diagnosis. It was at the sixth iteration that equilibrium was reached. The symptoms recorded for patient number Pat_1261 as shown in Table 2 are used to compute the scenarios in Table 3 and Table 4.
Ignoring symptoms that do not result in malaria for patient number Pat_1206, the initial vector is shown as the first row of Table 3 while the corresponding weight is represented in the second row of the table. Applying Equation (3), the results are generated until an equilibrium is found at the sixth iteration and the results are used to find the final diagnosis using the signum continuous activation function f ( x ) = 1 / 1 + e x . This gives 0.62 after the 6th iteration. The living condition and work habits of the patient were found to place the patient at risk of malaria, accounting for 0.17. The final diagnostic value of the patient is therefore put at 0.790.
Scenario 2: from the symptoms presented in Table 2, the symptoms associated with enteric fever are SWRFVR (0.75), HDACH (0.75), and LTG (0.58) and their weights are 0.23, 0.21, and 0.17, respectively. The computations for the diagnosis of enteric fever for PAT_No 1261 are shown in Table 4. After the 6th iteration, the signum activation is computed to give a diagnosis of 0.75 and the patient was not found to be at risk of enteric fever. The patient showed positive emotions that accorded about 5% (0.05) chance of not suffering from the disease, as computed by the FCM
Table 5 shows the final diagnosis as computed for patient number Pat_1261 for malaria, enteric fever, and other diseases. This shows the patient has comorbidity of malaria, enteric fever, upper respiratory-tract infection (URTI), lower respiratory-tract infection (LRTI), and tuberculosis (TB) diseases with varying degrees of severity. Equation (4) is used for the classification of the results.
F ( x ) = { 0.3 < = x < = 0.4 ………………… N o   D i s e a s e 0.4 < = x < = 0.5 ………………… V e r y   m i l d 0.5 < = x < = 0.6 ………………… M i l d 0.6 < = x < = 0.7 ………………… M o d e r a t e 0.7 < = x < = 0.8 ………………… H i g h 0.8 < = x > < = 1.0 ……………… v e r y   H i g h

4. Results and Discussion

4.1. Results

A sample result of the study is presented in Appendix C. It comprises 50 of the 2465 patients’ results of the datasets diagnosed by the domain experts and the computational results as processed by FCM.

4.2. Discussion

A binary classification of the results into patients diagnosed with a specific disease and those not diagnosed was carried out on the actual and predicted (computed) results. The performance evaluation of the 11 diseases is shown in Figure 4 and Table 6. From the results of these metrics, the true positive (TP), true negative (TN), false negative (FN), and true negative (TN) values were extracted, as shown in Table 7, while Table 8 presents the actual and predicted diagnosis for each disease. The average accuracies of 87%, precision of 53%, recall of 50%, and F1 of 51% were recorded. Four diseases (LWUTI, TB, LASFVR, and DENFVR) performed below 50% precision measure, while URUTI, LASFVR, YELFVR, and DENFVR performed below 50% of recall and the F1 measure had URUTI, TB, LASFVR, YELFVR, and DENFVR below 50%. Malaria has the highest number of diagnoses, of 1631 actual diagnostic results and 1721 predicted diagnoses. This is followed by enteric fever with 710 actual and 1072 predicted diagnoses.
There are fewer cases of predicted diagnoses than actual cases in HIVAD (270 actual and 209 predicted), URTI (478 actual and 179 predicted), LASFVR (13 actual and 4 predicted), and YELFVR (2 actual and 1 predicted), while DENFVR has an equal number (11) of actual and predicted results. The results of the number of diagnoses per disease are presented in Table 7. A total of 1050 patients representing 43% of the diagnoses have a comorbidity of between two and seven diseases. It was noticed that in most of the comorbidity of five to seven diseases, HIVAD, TB and MALARIA, were found in 79% of the comorbidities. Comorbidity on the actual results covary strongly with that of the predicted results. For instance, while patient number 14 suffered from six diseases in the predicted results, seven disease results, including HIVAD and TB, were found for the same patient in the predicted results.

4.3. The Implication of the Results

Results of the computations show that malaria is ranked first among the 11 diseases in terms of prevalence. This confirms a study by Crump et al. [12], which shows malaria as a default disease in tropical regions. The study has also revealed that malaria is comorbid to other diseases, with 830 cases representing 79%, indicating that most malaria patients need to be investigated for other diseases. According to Crump et al. [12], patients found to be negative for malaria tests are left unattended with the belief of wellbeing. That a patient is not positive for malaria does not suggest that the patient cannot suffer from other diseases. An FCM-based application can be used by the FHWs to diagnose febrile diseases, thereby curbing the problem of acute shortage of medical doctors, especially in rural settings [7]. This implies a life-saving measure for patients who resort to self-help because of delays in attending to them. Medical doctors will be relieved of the stress they undergo due to a large number of patients waiting to consult them on a daily basis. Such situations sometimes lead to wrong diagnoses, especially with overlapped symptoms that could be very difficult to differentiate by an inexperienced physician. According to Keller et al. [43], tropical diseases such as malaria, which are regarded as regional diseases, are increasingly encountered in the developed world due to travelers. There is a dearth of specialists in tropical diseases in the developed world; therefore, travelers from tropical regions are prone to these diseases but lack access to medical treatment. This gap could be bridged with an intelligent-decision support tool which such travellers will rely on for diagnosis and treatment of such diseases.
Ethical and policy implications are vital aspects of research that researchers should carefully consider. According to Goodman [44], making an accurate diagnosis is necessary for many more reasons than just the personal satisfaction that comes from being correct. It is based on the fact that accurate diagnoses have better outcomes more often than faulty diagnoses do. It is also predicated on the negative consequences that mistakes bring forth. Currently, there is an abuse of treatment of febrile diseases due to self-help carried out by patients. Misdiagnosis and inaccurate diagnosis are practised by drug vendors without following laid-down procedures for diagnosis and therapy. MDSS based on FCM has the potential to assist medical doctors, nurses, FHWs, and patients with some ethical concerns. MDSSs play a significant role in promoting an efficient and effective healthcare system [45]. To this end, a number of ethical issues that follow the use of intelligent machine diagnoses were followed in the process of data collection, planning, design, and development of this study. Computers are not meant to usurp the work of medical experts; the study is designed to aid experts through FHWs in taking the final decision on the state of wellbeing of a patient before a therapy decision is taken. As part of the work ethics and practice, the FHWs are the end users of the system and not the patient. The laid down procedures and standard guidelines accepted by the medical profession are used in implementing the study. The vulnerability and gender of a patient are respected and given due recognition from data gathering to modelling and the same goes for privacy and trust, which are also ensured. As the standards are revised, the MDSS is also revised with the responsibility of appropriate use of the system to optimize the ethical concerns to encourage the users. Adequate training of the FHWs on the use of an MDSS that results from this study to enhance its usage is part of ethics regulation. This is to ensure that the MDSS is used appropriately with no intention of abuse and to establish a lasting relationship between the developers and the medical practitioners. The relationship is meant to promote working ethics through thorough scrutiny of the datasets, procedures, rules, and standards that go into the development of the system [46]. This makes the development process both client and problem centred, using the Agile software engineering methodology [47]. The Beauchamp and Childress [48] principle of beneficence and nonmaleficence is employed to ensure the wellbeing of patients is maximized by assisting decision-makers as much as possible to deliver healthcare without let or hindrance. The certificate number for the study’s ethical approval is CRSMOH/RP/REC/2022/357.

5. Conclusions

The explicit knowledge embedded in fuzzy systems and the implicit knowledge in the neural networks are mapped cognitively to form a fuzzy cognitive map. FCM system provides a learning capability to adjust expert (physicians’) knowledge and automatically generate additional fuzzy rules and membership functions to aid in the diagnosis of a disease. FCM utilizes machine-learning algorithms to model a system. It models a system characterized by uncertainty, imprecision, causality, and complexity as found in medical diagnosis. These uncertainties and causalities are expressed in linguistic terms, which depict a causal relation between concepts where concepts are entities used in modelling FCM. Each concept represents a link to another concept with a degree of influence of a source concept to a destination concept.
In this study, 11 diseases and 50 symptoms represent the FCM concepts. The symptoms of the 11 febrile diseases were gathered from 3253 patients with febrile diseases. A total of 2465 of these are those 16 years and above whose records were used for the study. With the diagnoses done on these records by 62 physicians specializing in febrile diseases, the classification of the records was done in 11 clusters where each cluster represents each disease. FCM was then employed to mimic the physician’s diagnoses after the weight of the link between each of the source and destination concepts was determined and ascertained by 10 physicians. With the weights and the degree of symptoms for each patient, the values were fuzzified for the FCM using the Hebbian learning rule employed to determine the diagnostic value of the 2465 patients. Results obtained were compared with those obtained by the experts and found to covary positively.
Binary classification of the computed results was done using the confusion matrix, the results of the classification show an average accuracy of 87%, while the precision, recall, and F1 performance indicators had an average of 50%, respectively. One startling revelation of this study is the amount of comorbidity of the diseases in so many patients. A total of 1050 patients were found to have comorbidities ranging from two to seven diseases. Most of the comorbidities that are above four diseases had malaria, HIVAD and TB among the diseases. We hope to find the reasons behind these clusters of diseases in a patient in our future research. The use of decision-support filters to capture risk factors such as environmental factors and living conditions of a patient and emotional factors such as sadness, happiness, anxiety etc., was noticed as a gap in the literature which has been filled in this study.
These factors embedded in our study will help the system in mimicking the human-like reasoning of an expert while interrogating a patient, especially with the cognitive ability of FCM. A study by Keller et al. [43] shows that emotions such as anger, fear, boredom, etc., can lead to stress that is capable of increasing the degree of influence on a symptom of a disease. As a corollary, positive emotions such as love, happiness, success etc. can reduce stress and help to reduce the influence of a symptom. With a trustworthy reservoir of data and diagnostic results obtained from this study, a case-based reasoning (CBR) diagnostic methodology hybridized with FCM is suggested for further study to improve the results obtained here.
The imbalance of the datasets with malaria and enteric fever shows more than 80% of the entire datasets while yellow fever, dengue fever, and laser fever together form about 2% of the datasets is of concern. This imbalance would have contributed to the results not being so good. The early convergence of FCM is also a weakness of the study as can be seen in the equilibrium being reached at as low as six iterations in some cases. Further study is proposed with the exclusion of yellow fever, dengue fever, and laser fever. In the future, the research would be extended to interval type-2 and intuitionistic fuzzy logic.
The results of this study have been accepted by our team of medical doctors after evaluation but with a recommendation for parallel implementation with the conventional system of diagnosis. This is more so, given the fact that the app developed from the result is meant to be operated by FWHs and not the patients.

Author Contributions

Conceptualization, F.-M.U. and O.O.; methodology, O.O., A.J., U.U., S.U. and I.U.; validation, C.A. and E.D.; formal analysis, O.O. and A.J.; data curation, K.A., C.N. and E.J.; writing—original draft preparation, O.O. and F.-M.U.; writing—review and editing, O.O., C.N. and K.A.; supervision, F.-M.U.; project administration, F.-M.U. and O.O.; funding acquisition, F.-M.U. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the New Frontier Research Fund, grant number NFRFE-2019-01365.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors are grateful to Mount Royal University, Alberta, Canada, the Institute of Health Research and Development, the University of Uyo Teaching Hospital, Nigeria, and the Department of Computer Science, University of Uyo, Nigeria. The team of medical experts who assisted in the collection of data and in assigning weights to the symptoms of the diseases: Nnette Ekpenyong (University of Calabar), Chimaobi Isiguzo (Federal Medical Centre, Owerri), Victory Ekpin, (Health Systems Research Hub), Uwemedimbuk Ekanem, and Olugbemi Motilewa.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the study’s design; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Appendix A. Symptom Rankings for Diseases

Table A1. Symptom rankings for Enteric Fever.
Table A1. Symptom rankings for Enteric Fever.
SNENFVR
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1ABDPN0.2490.2250.2500.24
2SWRFVR0.2270.2170.2360.23
3HDACH0.2120.1960.2240.21
4DIZ0.1860.2060.2260.21
5NUS0.1850.1920.2110.20
6DRH0.2010.1780.1910.19
7LTG0.1670.1580.1740.17
8CNST0.1510.1670.1780.17
9INTBLEPRF0.1450.1380.1470.14
10PERTN0.1250.1280.1360.13
Table A2. Symptom rankings for HIV/AIDS.
Table A2. Symptom rankings for HIV/AIDS.
SNHVAD
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1GENRSH0.4190.4300.4430.43
2SKNRSH0.4170.4180.4320.42
3MUTUCR0.3830.3300.3410.35
4LMPNDSWL0.4020.3200.3310.35
5DRH0.2990.2760.2870.29
6BDYICH0.2320.2460.2560.24
7NGTSWT0.2390.1960.2070.21
8SRTRT0.1920.2100.2180.21
9FOLBRT0.2040.1880.1950.20
10CGHDRY0.1950.1690.1800.18
11DRYCGH0.1600.1420.1500.15
12DRYCGH0.1460.1330.1410.14
13LTG0.1210.0870.0930.10
14DIZ0.0990.0730.0780.08
15LWGDFVR0.0790.0810.0880.08
Table A3. Symptom rankings for Upper Urinary-Tract Infection (UPUTI).
Table A3. Symptom rankings for Upper Urinary-Tract Infection (UPUTI).
SNUPUTI
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1PNFLURNTN0.5530.5030.5290.53
2URNFQC0.5530.4870.5140.52
3SPPBPN0.5090.4790.5060.50
4CLDYURN0.5080.4430.4650.47
5BLDYURN0.2440.2380.2470.24
6ABDPN0.2160.2220.2430.23
7UPBCKPN0.1960.2110.2230.21
8BCKPN0.1770.1890.2030.19
9NUS0.1440.1510.1630.15
10SUDONFVR0.1240.1250.1350.13
11HGPSFVR0.1270.1200.1310.13
Table A4. Symptom rankings for Lower Urinary-Tract Infection (LWUTI).
Table A4. Symptom rankings for Lower Urinary-Tract Infection (LWUTI).
SNLWUTI
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1URNFQC0.5920.5510.5840.58
2PNFLURNTN0.5890.5540.5840.58
3SPPBPN0.5280.5290.5620.54
4CLDYURN0.4870.4650.4930.48
5BLDYURN0.2680.2630.2770.27
6ABDPN0.2120.2250.2490.23
7UPBCKPN0.1940.1950.2070.20
8BCKPN0.1200.1400.1520.14
9LWGDFVR0.1060.1020.1130.11
Table A5. Symptom rankings Upper Respiratory-Tract Infection (URTI).
Table A5. Symptom rankings Upper Respiratory-Tract Infection (URTI).
SNURTI
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1CTRH0.4470.4030.4290.43
2CGHDRY0.4070.4140.4440.42
3SRTRT0.3140.3270.3460.33
4DIFBRT0.3020.3180.3380.32
5DRYCGH0.3140.3000.3220.31
6DRYCGH0.3110.2960.3170.31
7FOLBRT0.2220.2460.2600.24
8MUTUCR0.1180.1630.1720.15
9FTG0.1120.1200.1350.12
10HDACH0.1020.1050.1200.11
11LWGDFVR0.0570.0760.0830.07
Table A6. Symptom rankings for Lower Respiratory-Tract Infection.
Table A6. Symptom rankings for Lower Respiratory-Tract Infection.
SNLRTI
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1CGHDRY0.5240.4800.5130.51
2DIFBRT0.4290.4350.4610.44
3CHSPN0.4110.4100.4380.42
4WHZ0.3390.3400.3550.34
5CHSIND0.3210.3290.3440.33
6DRYCGH0.2820.2930.3130.30
7DRYCGH0.2780.2820.3010.29
8LMPNDSWL0.2290.2590.2720.25
9FOLBRT0.2350.2540.2680.25
10NGTSWT0.2410.2470.2630.25
11SRTRT0.2190.2540.2680.25
12CTRH0.2090.2190.2350.22
13MUTUCR0.1770.2130.2230.20
14LWGDFVR0.0780.0990.1080.09
Table A7. Symptom rankings for Tuberculosis (TB).
Table A7. Symptom rankings for Tuberculosis (TB).
SNTB
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1CGHDRY0.4810.4190.4430.45
2NGTSWT0.5030.3920.4090.43
3CHSPN0.3900.3730.3910.38
4DIFBRT0.3100.3340.3480.33
5LMPNDSWL0.3450.3150.3270.33
6MUTUCR0.2690.2710.2790.27
7FOLBRT0.2750.2610.2700.27
8CHSIND0.2510.2660.2730.26
9WHZ0.2440.2650.2720.26
10SRTRT0.2150.2330.2430.23
11DRYCGH0.2330.2210.2330.23
12DRYCGH0.2230.2140.2260.22
13LWGDFVR0.2180.1850.2000.20
Table A8. Symptom rankings for Laser Fever (LASFVR).
Table A8. Symptom rankings for Laser Fever (LASFVR).
SNLASFVR
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1REDEYE0.2160.1810.1820.19
2REDEYEFCTNG0.2470.1650.1660.19
3SENLHT0.2010.0990.1000.13
4PNBHEYE0.1500.1060.1070.12
5JNTSWL0.1130.1140.1150.11
6PERTN0.1200.1070.1080.11
7BLDYURN0.0890.1180.1190.11
8SHK0.1310.0870.0870.10
9SRTRT0.1110.0820.0840.09
10UPBCKPN0.0700.0890.0910.08
11SUDONFVR0.0870.0760.0810.08
12BLDN0.0860.0760.0760.08
Table A9. Symptom rankings for Yellow Fever (YELFVR).
Table A9. Symptom rankings for Yellow Fever (YELFVR).
SNYELFVR
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1PERTN0.1030.0930.0940.10
2JNTSWL0.0720.0810.0820.08
3DRH0.0510.0800.0820.07
4BDYICH0.0680.0710.0720.07
5SHK0.0610.0730.0740.07
6LMPNDSWL0.0620.0710.0720.07
7SENLHT0.0930.0520.0530.07
8GENRSH0.0730.0620.0630.07
9INTBLEPRF0.0550.0690.0700.06
10BLDN0.0630.0630.0640.06
11HGPSFVR0.0380.0680.0720.06
Table A10. Symptom rankings for DENGUE Fever (DENFVR).
Table A10. Symptom rankings for DENGUE Fever (DENFVR).
SNDENFVR
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1REDEYE0.0540.1300.1310.10
2REDEYEFCTNG0.0660.1010.1010.09
3HGGDFVR0.0780.0830.0890.08
4UPBCKPN0.0530.0900.0920.08
5SENLHT0.0480.0880.0890.08
6SKNRSH0.0550.0790.0800.07
7BCKPN0.0530.0770.0810.07
8PNBHEYE0.0590.0750.0760.07
9SHK0.0720.0690.0700.07
10PERTN0.0520.0590.0590.06
11LMPNDSWL0.0470.0600.0620.06
12INTBLEPRF0.0560.0550.0560.06
13DIZ0.0400.0610.0650.06
14ABDPN0.0470.0560.0600.05
15GENRSH0.0310.0650.0660.05
16CHSPN0.0380.0590.0610.05
17HGPSFVR0.0250.0620.0660.05
18FTG0.0370.0470.0520.05
19DIFBRT0.0300.0510.0520.04
20MSCBDYPN0.0420.0430.0460.04
21BLDYURN0.0220.0540.0540.04
22GENBDYPN0.0390.0420.0460.04

Appendix B. Symptoms, Diseases and Their Meaning

Table A11. Acronyms and their Meanings for the Symptoms and Diseases.
Table A11. Acronyms and their Meanings for the Symptoms and Diseases.
LabelSymptomMeaningLabelSymptomMeaningLabelSymptomMeaning
T1ABDPNabdominal painT21SWRFVRstepwise rise feverT41REDEYERed eye
T2BCKPNback painT22SUDONFVRsudden onset feverT42REDEYEFCTNGred eye face and tongue
T3BITAIMbitter test in mouthT23LWGDFVRlow-grade feverT43SENLHTsensitivity to light
T4BLDNbleeding from any sightT24FOLBRTfoul breatheT44SHKshock
T5BLDYURNbloody urineT25BDYICHbody itchingT45SKNRSHskin rash
T6CTRHCatarrhT26GENBDYPNgeneralized body painT46SRTRTsore throat
T7CHSINDchest indrawT27GENRSHgeneralized rashesT47SPPBPNsuprapubic pains
T8CHSPNchest painT28HDACHHeadacheT48URNFQCurinary frequency
T9CHLNRIGchills and rigoursT29INTBLEPRFintestinal bleeding and perforationT49VMTvomiting
T10CLDYURNcloudy urineT30JNTSWLjoint swellingT50WHZwheeze
T11CNSTconstipationT31LTGlethargy
T12CGHDRYcough initial dryT32LMPNDSWLlymph node swellingD1MALmalaria
T13DRHdiarrhoeaT33MSCBDYPNmuscle and body painD2ENFVRenteric ever
T14DIFBRTdifficulty breathingT34MUTUCRmouth ulcerD3HVADHIV/AIDS
T15DIZdizzinessT35NUSnauseaD4UPUTIupper urinary-tract infection
T16DRYCGHdry coughT36NGTSWTnight sweatsD5LWUTIlower urinary-tract infection
T17FTGFatigueT37PNBHEYEpain behind eyeD6URTIupper respiratory-tract infection
T18FVRFeverT38UPBCKPNupper back painD7LRTIlower respiratory-tract infection
T19HGPSFVRhigh persistent feverT39PNFLURNTNpainful urinationD8TBtuberculosis
T20HGGDFVRhigh grade feverT40PERTNperitonitisD9LASFVRLaser Fever
D10YELFVRYellow Fever
D11DENFVRDengue Fever

Appendix C. Sample Results

Table A12. Malaria(MAL) to Upper Urinary Tract Infection(UPUTI) Results.
Table A12. Malaria(MAL) to Upper Urinary Tract Infection(UPUTI) Results.
Pat_NoMal_DataDiagnosisFCM_MalDiagnosisEnt_DataDiagnosisFCM_EntDiagnosisHivAd_DataDiagnosisFCM_HivAdDiagnosisUputi_dataDiagnosisFCM_UputiDiagnosis
12610.91MAL0.7888MAL0.08No0.701ENTFV0.08NO0.795No0.08No0.6082No
13770.58MAL0.6727MAL0.08No0.3603No0.08NO0.4223No0.08No0.4782No
14590.08No0.2832No0.08No0.3212No0.08NO0.4835No0.08No0.5132No
14800.58MAL0.9987MAL0.58ENTFV0.5524ENTFV0.08NO0.3832No0.08No0.516No
1510.58MAL0.6151MAL0.08No0.4334No0.08NO0.3968No0.08No0.5173No
15940.58MAL0.6419MAL0.08No0.3212No0.08NO0.3968No0.08No0.434No
17280.58MAL0.7083MAL0.58ENTFV0.5474ENTFV0.58HVAD0.7915No0.08No0.5277No
19020.75MAL0.9452MAL0.75ENTFV0.6157ENTFV0.08NO0.4162No0.08No0.5528No
20190.08No0.3822No0.08No0.4004No0.08NO0.4138No0.08No0.6419No
20540.58MAL0.6181MAL0.91ENTFV0.8359ENTFV0.08NO0.4699No0.08No0.5927No
20550.75MAL0.7652MAL0.41ENTFV0.8877ENTFV0.08NO0.8364HVAD0.08No0.797No
21060.58MAL0.6134MAL0.75ENTFV0.9595ENTFV0.08NO0.5586No0.41UPUTI0.978UPUTI
21830.41MAL0.8928MAL0.41ENTFV0.6858ENTFV0.08NO0.8977HVAD0.08No0.6686No
23650.25MAL0.4666No0.58ENTFV0.6031ENTFV0.08NO0.3968No0.08No0.5881No
24170.08No0.6344MAL0.08No0.638ENTFV0.08NO0.4232No0.08No0.5226No
26220.75MAL0.7044MAL0.75ENTFV0.6647ENTFV0.08NO0.86HVAD0.08No0.564No
28460.75MAL0.6576MAL0.41ENTFV0.6022ENTFV0.08NO0.4597No0.08No0.4835No
29580.75MAL0.8948MAL0.75ENTFV0.8347ENTFV0.08NO0.5859No0.08No0.7519No
29830.08No0.4082No0.08No0.467No0.08NO0.4232No0.08No0.5054No
30560.91MAL0.7035MAL0.08No0.3212No0.08NO0.5137No0.08No0.434No
32370.41MAL0.7368MAL0.08No0.4719No0.08NO0.4667No0.08No0.5347No
34990.75MAL0.7079MAL0.08No0.4466No0.08NO0.4519No0.08No0.434No
3500.58MAL0.6704MAL0.08No0.5976ENTFV0.08NO0.6519No0.25UPUTI0.969UPUTI
35620.08No0.4119No0.08No0.4664No0.08NO0.3832No0.08No0.5594No
35820.58MAL0.7343MAL0.58ENTFV0.5578ENTFV0.08NO0.4232No0.08No0.4769No
36240.75MAL0.6654MAL0.91ENTFV0.797ENTFV0.08NO0.4718No0.08No0.8133UPUTI
36830.41MAL0.6176MAL0.58ENTFV0.852ENTFV0.75HVAD0.9717HVAD0.58UPUTI0.9UPUTI
37370.08No0.5208No0.08No0.4664No0.08NO0.3832No0.08No0.5594No
37380.08No0.5208No0.08No0.4664No0.08NO0.3832No0.08No0.5594No
38860.58MAL0.7871MAL0.58ENTFV0.4423No0.08NO0.3832No0.08No0.4769No
38900.58MAL0.7079MAL0.58ENTFV0.5474ENTFV0.08NO0.5251No0.08No0.5693No
42210.75MAL0.8449MAL0.08No0.4004No0.08NO0.4232No0.08No0.5099No
44900.08No0.6315MAL0.08No0.4434No0.58HVAD0.8481HVAD0.08No0.434No
46440.58MAL0.7216MAL0.58ENTFV0.6535ENTFV0.08NO0.3832No0.08No0.4835No
47420.41MAL0.6811MAL0.08No0.3212No0.08NO0.3832No0.08No0.4769No UPUTI
4790.25MAL0.7379MAL0.58ENTFV0.5875ENTFV0.08NO0.4096No0.08No0.4769No
7970.08No0.5769No0.75ENTFV0.6548ENTFV0.08NO0.7837No0.08No0.7335No UPUTI
8020.08No0.5769No0.75ENTFV0.6548ENTFV0.08NO0.7837No0.08No0.7335No
12240.91MAL0.7292MAL0.91ENTFV0.8821ENTFV0.08NO0.6275No0.08No0.8373UPUTI
1290.08No0.2832No0.08No0.3212No0.08NO0.3832No0.08No0.434No
13640.08No0.5451No0.75ENTFV0.5888ENTFV0.75HVAD0.556No0.08No0.499No
13740.08No0.6869MAL0.58ENTFV0.5507ENTFV0.58HVAD0.5179No0.08No0.4782No
15840.08No0.2832No0.08No0.3212No0.08NO0.3832No0.08No0.434No
1740.58MAL0.6079MAL0.91ENTFV0.8052ENTFV0.08NO0.3968No0.08No0.5985No
1830.08No0..8079MAL0.08No0.8052ENTFV0.08NO0.3968No0.08No0.5985No
20230.75MAL0.8929MAL0.08No0.3926No0.08NO0.4727No0.08No0.434No
20240.75MAL0.7779MAL0.41ENTFV0.5887ENTFV0.08NO0.3968No0.58UPUTI0.782No UPUTI
20450.91MAL0.8546MAL0.41ENTFV0.7918ENTFV0.08NO0.4426No0.08No0.7668No UPUTI
20880.41MAL0.5897No0.08No0.4181No0.08NO0.5935No0.08No0.4731No UPUTI
Table A13. Lower Unrinary Tract Infection(LWUTI) to Tuberculosis(TB) Results.
Table A13. Lower Unrinary Tract Infection(LWUTI) to Tuberculosis(TB) Results.
Pat_NoLwuti_DataDiagnosisFCM_LwutiDiagnosisUrti_DataDiagnosisFCM_UrtiDiagnosisLrti_DataDiagnosisFCM_LrtiDiagnosisTB_DataDiagnosisFCM_TBDiagnosis
12610.08No0.40No0.91URTI0.892URTI0.08No0.9434LRTI0.08No TB0.7501TB
13770.08No0.79No0.58URTI0.5492No0.08No0.5669No0.08No TB0.3843No TB
14590.75LWUTI0.864LWUTI0.08No0.2505No0.08No0.462No0.08No TB0.3571No TB
14800.08No0.51No0.08No0.2783No0.08No0.428No0.08No TB0.3112No TB
1510.08No0.51No0.08No0.2403No0.08No0.428No0.08No TB0.3112No TB
15940.08No0.49No0.08No0.3754No0.08No0.5159No0.08No TB0.3452No TB
17280.08No0.49No0.08No0.469No0.08No0.6966No0.08No TB0.5787TB
19020.08No0.65No0.08No0.2816No0.08No0.428No0.08No TB0.3112No TB
20190.08No0.981LWUTI0.08No0.293No0.08No0.5147No0.08No TB0.3877No TB
20540.08No0.77No0.08No0.3162No0.08No0.428No0.08No TB0.3112No TB
20550.08No0.892LWUTI0.08No0.6618No0.08No0.7454No0.08No TB0.6142TB
21060.58LWUTI0.921LWUTI0.08No0.4268No0.08No0.553No0.08No TB0.4432No TB
21830.08No0.864LWUTI0.41URTI0.871URTI0.91LRTI0.9204LRTI0.91TB0.9922TB
23650.08No0.543LWUTI0.08No0.2335No0.08No0.4433No0.08No TB0.3452No TB
24170.08No0.671No0.08No0.297No0.08No0.428No0.08No TB0.3112No TB
26220.08No0.783No0.75URTI0.8249URTI0.08No0.8363LRTI0.75TB0.8226TB
28460.08No0.657No0.08No0.3162No0.08No0.4705No0.08No TB0.3673No TB
29580.08No0.846LWUTI0.08No0.3502No0.08No0.4858No0.08No TB0.3911No TB
29830.08No0.73No0.08No0.336No0.08No0.6117No0.08No TB0.4531No TB
30560.08No0.567No0.08No0.2743No0.08No0.604No0.08No TB0.5653TB
32370.08No0.721No0.08No0.3834No0.08No0.5695No0.08No TB0.433No TB
34990.08No0.432No0.08No0.2783No0.08No0.4705No0.08No TB0.3843No TB
3500.08No0.965LWUTI0.08No0.5196No0.08No0.8165LRTI0.08No TB0.8177TB
35620.08No0.6545No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
35820.08No0.4323No0.08No0.2929No0.08No0.473No0.08No TB0.4112No TB
36240.08No0.8542LWUTI0.41URTI0.8058URTI0.41LRTI0.9551LRTI0.08No TB0.7166TB
36830.58LWUTI0.879LWUTI0.41URTI0.7496No0.41LRTI0.8036LRTI0.58TB0.8128TB
37370.08No0.65No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
37380.08No0.435No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
38860.08No0.567No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
38900.08No0.677No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
42210.08No0.905LWUTI0.08No0.2962No0.08No0.473No0.08No TB0.4112No TB
44900.08No0.543No0.08No0.5862No0.08No0.7349No0.08No TB0.5414TB
46440.08No0.432No0.08No0.2579No0.08No0.428No0.08No TB0.3112No TB
47420.08No0.432No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
4790.08No0.785No0.08No0.3206No0.08No0.4577No0.08No TB0.3772No TB
7970.08No0.965LWUTI0.08No0.2579No0.08No0.428No0.08No TB0.3112No TB
8020.08No0.8965LWUTI0.08No0.2579No0.08No0.428No0.08No TB0.3112No TB
12240.08No0.971LWUTI0.08No0.3757No0.08No0.428No0.08No TB0.3112No TB
1290.08No0.77No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
13640.08No0.69No0.08No0.2698No0.08No0.4433No0.08No TB0.3452No TB
13740.08No0.49No0.08No0.3094No0.08No0.4433No0.08No TB0.3452No TB
15840.08No0.647No0.08No0.2216No0.08No0.428No0.08No TB0.3112No TB
1740.08No0.919LWUT0.08No0.2975No0.08No0.428No0.08No TB0.3112No TB
1830.08No0.935LWUT0.08No0.2975No0.08No0.428No0.08No TB0.3112No TB
20230.08No0.431No0.08No0.3861No0.08No0.5567No0.08No TB0.4531No TB
20240.41LWUTI0.8654LWUTI0.08No0.2522No0.08No0.5147No0.08No TB0.4098No TB
20450.08No0.874LWUTI0.08No0.3162No0.08No0.428No0.08No TB0.3112No TB
20880.08No0.95LWUT0.75URTI0.8871URTI0.41LRTI0.878LRTI0.08No TB0.6539TB
Table A14. Lassa Fever(LASFVR) to Dengue Fever(DENFVR) Results.
Table A14. Lassa Fever(LASFVR) to Dengue Fever(DENFVR) Results.
Pat_NoLasfv_DataDiagnosisFCM_lasfvDiagnosisYelfv_DataDiagnosisFCM_YelfvDiagnosisDenfv_DataDiagnosisFCM_DenfvDiagnosis
12610.08No0.7451No0.08No0.6226No0.08No0.7809No
13770.08No0.6448No0.08No0.5926No0.08No0.6509No
14590.08No0.6675No0.08No0.5943No0.08No0.642No
14800.08No0.6312No0.08No0.6022No0.08No0.7023No
1510.08No0.6448No0.08No0.5926No0.08No0.6696No
15940.08No0.6312No0.08No0.5824No0.08No0.6288No
17280.08No0.6601No0.08No0.6045No0.08No0.6713No
19020.08No0.6312No0.08No0.6022No0.08No0.6936No
20190.08No0.6939No0.08No0.6088No0.08No0.7212No
20540.08No0.6448No0.08No0.6345No0.08No0.7575No
20550.08No0.9334LASFVR0.08No0.9036No0.08No1.581No
21060.08No0.6932No0.08No0.6413No0.08No0.829No
21830.08No0.8012No0.08No0.626No0.08No0.8661No
23650.08No0.6312No0.08No0.5824No0.08No0.6623No
24170.08No0.6312No0.08No0.5824No0.08No0.6758No
26220.08No0.6712No0.08No0.6355No0.08No0.7703No
28460.08No0.6312No0.08No0.5943No0.08No0.7091No
29580.08No0.6856No0.08No0.648No0.08No0.6957No
29830.08No0.6712No0.08No0.6124No0.08No0.724No
30560.08No0.6448No0.08No0.5926No0.08No0.682No
32370.08No0.6652No0.08No0.6124No0.08No0.7393No
34990.08No0.6312No0.08No0.5824No0.08No0.65No
3500.08No0.756No0.08No0.661No0.08No0.8382No
35620.08No0.6312No0.08No0.5824No0.08No0.6453No
35820.08No0.6576No0.08No0.6418No0.08No0.6651No
36240.08No0.7448No0.08No0.6124No0.08No0.8425No
36830.08No0.6894No0.08No0.6688No0.08No0.7573No
37370.08No0.6312No0.08No0.5824No0.08No0.6453No
37380.08No0.6312No0.08No0.5824No0.08No0.6453No
38860.08No0.6312No0.08No0.6022No0.08No0.6849No
38900.08No0.6576No0.08No0.6253No0.08No0.7014No
42210.08No0.6312No0.08No0.5824No0.08No0.675No
44900.08No0.6312No0.08No0.6276No0.08No0.6543No
46440.08No0.6576No0.08No0.6022No0.08No0.6552No
47420.08No0.6576No0.08No0.5824No0.08No0.6288No
4790.08No0.6312No0.08No0.6022No0.08No0.6882No
7970.08No0.6312No0.08No0.6405No0.08No0.682No
8020.08No0.6312No0.08No0.6405No0.08No0.682No
12240.08No0.6848No0.08No0.6695No0.08No0.8029No
1290.08No0.6312No0.08No0.5824No0.08No0.6288No
13640.08No0.6448No0.08No0.6022No0.08No0.6589No
13740.08No0.6448No0.08No0.5926No0.08No0.6674No
15840.08No0.6312No0.08No0.5824No0.08No0.6288No
1740.08No0.6312No0.08No0.5824No0.08No0.7273No
1830.08No0.6312No0.08No0.5824No0.08No0.7273No
20230.08No0.6312No0.08No0.5824No0.08No0.6543No
20240.08No0.6576No0.08No0.6226No0.08No0.738No
20450.08No0.6312No0.08No0.6124No0.08No0.7846No
20880.08No0.6312No0.08No0.5824No0.08No0.6538No

References

  1. Oken, D. Multiaxial diagnosis and the psychosomatic model of disease. Psychosom. Med. 2000, 62, 171–175. [Google Scholar] [CrossRef] [PubMed]
  2. Graber, M.L. The incidence of diagnostic error in medicine. BMJ Qual. Saf. 2013, 22 (Suppl. S2), ii21–ii27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Attai, K.; Amannejad, Y.; Vahdat Pour, M.; Obot, O.; Uzoka, F.M. A Systematic Review of Applications of Machine Learning and Other Soft Computing Techniques for the Diagnosis of Tropical Diseases. Trop. Med. Infect. Dis. 2022, 7, 398. [Google Scholar] [CrossRef]
  4. Johnson-Laird, P.N.; Khemlani, S.S.; Goodwin, G.P. Logic, probability, and human reasoning. Trends Cogn. Sci. 2015, 19, 201–214. [Google Scholar] [CrossRef] [Green Version]
  5. De Silva, C.W. Intelligent Control: Fuzzy Logic Applications; CRC Press: Boca Raton, FL, USA, 2018. [Google Scholar]
  6. Mehta, A.; Awuah, W.A.; Aborode, A.T.; Ng, J.C.; Candelario, K.; Vieira, I.M.P.; Bulut, H.I.; Toufik, A.-R.; Hasan, M.M.; Sikora, V. Telesurgery’s potential role in improving surgical access in Africa. Ann. Med. Surg. 2022, 82, 104511. [Google Scholar] [CrossRef] [PubMed]
  7. WHO. The State of the Health Workforce in the WHO African Region; World Health Organization Universal Health Coverage/Life Course Cluster Brazzaville: Brazzaville, Congo, 2021. [Google Scholar]
  8. Prasad, N.; Murdoch, D.R.; Reyburn, H.; Crump, J.A. Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review. PLoS ONE 2015, 10, e0127962. [Google Scholar] [CrossRef] [Green Version]
  9. Bell, D. Acute Febrile Syndrome Strategy: A Major Challenge to Global Public Health; Foundation for Innovation New Diagnostic (FIND) Communications, 2012; pp. 1–36. Available online: https://assets.publishing.service.gov.uk/media/57a08a7340f0b652dd00072c/0031-FIND-NMFI-document-print-inhouse.pdf (accessed on 22 January 2023).
  10. Crump, J.A. Time for a Comprehensive Approach to the Syndrome of Fever in the Tropics. Trans. R. Soc. Trop. Med. Hyg. 2014, 108, 61–62. [Google Scholar] [CrossRef] [Green Version]
  11. Crump, J.; Newton, P.; Baird, S.; Lubell, Y. Febrile illness in adolescents and adults–ORA–Oxford University Research Archive. Febrile Illness in Adolescents and Adults–ORA–Oxford University Research Archive. 2017, pp. 1–40. Available online: https://ora.ox.ac.uk/objects/uuid:808876da-b46f-4307-b8a4-43cfc914273a (accessed on 22 January 2023).
  12. Crump, J.A.; Ramadhani, H.O.; Morrissey, A.B.; Saganda, W.; Mwako, M.S. Invasive Bacterial and Fungal Infections among Hospitalized HIV-Infected and HIV-Uninfected Adults and Adolescents in Northern Tanzania. Clin. Infect. Dis. 2011, 52, 341–348. [Google Scholar] [CrossRef]
  13. WHO. WHO Informal Consultation on Fever Management in Peripheral Health Care Settings: A Global Review of Evidence and Practice; WHO: Geneva, Switzerland, 2013; pp. 1–66. [Google Scholar]
  14. Nabarro, L.E.; McCann, N.; Herdman, M.T.; Dugan, C.; Ladhani, S.; Patel, D.; Morris-Jones, S.; Balasegaram, S.; Heyderman, R.S.; Brown, M. British infection association guidelines for the diagnosis and management of enteric fever in England. J. Infect. 2022, 84, 469–489. [Google Scholar] [CrossRef]
  15. Goletti, D.; Delogu, G.; Matteelli, A.; Migliori, G.B. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int. J. Infect. Dis. 2022, 124, S12–S19. [Google Scholar] [CrossRef]
  16. Maillard, O.; Belot, J.; Adenis, T.; Rollot, O.; Adenis, A.; Guihard, B.; Gérardin, P.; Bertolotti, A. Early diagnosis of dengue: Diagnostic utility of the SD BIOLINE Dengue Duo rapid test in Reunion Island. PLoS Negl. Trop. Dis. 2023, 17, e0011253. [Google Scholar] [CrossRef] [PubMed]
  17. Bhaskaran, D.; Chadha, S.; Sarin, S.; Sen, R.; Arafah, S.; Dittrich, S. Diagnostic tools used in the evaluation of acute febrile illness in South India: A scoping review. BMC Infect. Dis. 2019, 19, 970. [Google Scholar] [CrossRef] [PubMed]
  18. Das, S.; Guha, D.; Dutta, B. Medical diagnosis with the aid of using fuzzy logic and intuitionistic fuzzy logic. Appl. Intell. 2016, 45, 850–867. [Google Scholar] [CrossRef]
  19. Nilashi, M.; Ibrahim, O.; Ahmadi, H.; Shahmoradi, L. A knowledge-based system for Breast cancer classification using fuzzy logic method. Telemat. Inform. 2017, 34, 133–144. [Google Scholar] [CrossRef]
  20. Amjad, M.; Ameer, I.; Gelbukh, A. A distinct approach to diagnose Dengue Fever with the help of Soft Set Theory. arXiv 2018. [Google Scholar] [CrossRef]
  21. Sharma, M.K.; Dhiman, N.; Mishra, V.N.; Mishra, L.N.; Dhaka, A.; Koundal, D. Post-symptomatic detection of COVID-2019 grade based mediative fuzzy projection. Comput. Electr. Eng. 2022, 101, 108028. [Google Scholar] [CrossRef]
  22. Magwili, G.V.; Latina, M.A.E.; Miguel, F.I.C.; Ortega, T.K.P.; Pastoril, T.K.L.; Tanglao, E.J.D. Raspberry pi-based medical expert system for pre-diagnosis of mosquito-borne diseases. In Proceedings of the 2018 IEEE 10th Inter-national Conference on Humanoid, Nanotechnology, Information Technology, Communication and Control, Environment and Management (HNICEM), Baguio City, Philippines, 29 November–2 December 2018; IEEE: Piscataway, NJ, USA, 2018; pp. 1–6. [Google Scholar] [CrossRef]
  23. Putra, I.K.G.D.; Prihatini, P.M. Fuzzy expert system for tropical infectious disease by certainty factor. TELKOMNIKA (Telecommun. Comput. Electron. Control) 2012, 10, 825–836. [Google Scholar] [CrossRef] [Green Version]
  24. Ekong, B.; Ifiok, I.; Udoeka, I.; Anamfiok, J. Integrated fuzzy based decision support system for the management of human dis-ease. Int. J. Adv. Comput. Sci. Appl. 2020, 11, 268–274. [Google Scholar] [CrossRef] [Green Version]
  25. Bourgani, E.; Stylios, C.D.; Georgopoulos, V.C.; Manis, G. A study on Fuzzy Cognitive Map structures for Medical Decision Support Systems. In Proceedings of the 8th Conference of the European Society for Fuzzy Logic and Technology (EUSFLAT 2013), Milan, Italy, 11–13 September 2013; Atlantis Press: Amsterdam, The Netherlands, 2013; pp. 744–751. [Google Scholar] [CrossRef] [Green Version]
  26. Amirkhani, A.; Papageorgiou, E.; Mosheni, A.; Mosavi, M. A Review of Fuzzy Cognitive map in Medicine: Taxonomy Methods and Applications. Comput. Methods Programs Biomed. 2017, 142, 129–145. [Google Scholar] [CrossRef]
  27. Groumpos, P.P. Modelling COVID-19 using Fuzzy Cognitive Maps (FCM). EAI Endorsed Transaction. Bioeng. Bioinform. 2021, 21, e3. [Google Scholar] [CrossRef]
  28. Papageorgiou, E.I.; Papandrianos, N.I.; Karagianni, G.; Kyriazopoulos, G.C.; Sfyras, D. A Fuzzy Cognitive Map based tool for prediction of infectious diseases. In Proceedings of the IEEE International Conference on Fuzzy Systems, Jeju, Republic of Korea, 20–24 August 2009. [Google Scholar] [CrossRef]
  29. N’apoles, G.; Espinosa, M.; Grau, I.; Vanhoof, K. FCM Expert: Software Tool for Scenario Analysis and Pattern Classification Based on Fuzzy Cognitive Maps. Int. J. Artif. Intell. Tools 2018, 27, 1860010. [Google Scholar] [CrossRef]
  30. Mpelogianni, V.; Groumpos, P.P. Re-approaching Fuzzy Cognitive Maps to increase Knowledge of system. Ai Soc. 2018, 33, 175–188. [Google Scholar] [CrossRef]
  31. Apotolospoulos, I.D.; Groumpos, P.P. Fuzzy Cognitive Maps: The Role of explainable Artificial Intelligence. Appl. Sci. 2023, 13, 3412. [Google Scholar] [CrossRef]
  32. Obot, O.U.; Udo, I.I.; Udoh, S.S. Differential Diagnosis of Eye Diseases Based on Fuzzy Cognitive Map. IOSR J. Nurs. Health Sci. (IOSR-JNHS) 2018, 7, 42–52. [Google Scholar]
  33. Apostolopoulos, I.D.; Groumpos, P.P.; Apostolopoulos, D.I. Advanced Fuzzy Cognitive Maps: State Space and Rule Based methodology for Coronary Artery Disease detection. Biomed. Phys. Eng. Express 2020, 7, 045007. [Google Scholar] [CrossRef]
  34. Apostolopoulos, I.D.; Groumpos, P.P. Non-invasive modelling methodology for the diagnosis of coronary artery disease using fuzzy cognitive maps. Comput. Methods Biomech. Biomed. Eng. 2020, 23, 879–887. [Google Scholar] [CrossRef]
  35. Bourgani, E.; Stylios, C.D.; Manis, G.; Georgopoulos, V.C. Time depend-ent fuzzy cognitive maps for medical diagnosis. In Artificial Intelligence: Methods and Applications: Proceedings of the 8th Hellenic Conference on AI, SETN 2014, Ioannina, Greece, 15–17 May 2014; Springer: Berlin/Heidelberg, Germany, 2014; pp. 544–554. [Google Scholar]
  36. Uzoka, F.M.; Akinnwunesi, B.A.; Amoo, T.; Aladi, F.; Fashoto, S.; Olaniyan, M.; Osuji, J. A Framework for Early Differential Diagnosis of Tropical Confusable Diseases using Fuzzy Cognitive Map. Int. J. Health Med. Eng. 2016, 10, 346–353. [Google Scholar]
  37. Uzoka, F.M.E.; Akinnuwesi, B.A.; Amoo, T.; Debele, F.; Fashoto, G.; Nwafor-Okoli, C. An expert system for malaria diagnosis using the fuzzy cognitive map engine. In Proceedings of the 2018 IST-Africa Week Conference (IST-Africa), Gaborone, Botswana, 9–11 May 2018; IEEE: Piscataway, NJ, USA, 2018; pp. 1–13. [Google Scholar]
  38. Hoyos, W.; Aguilar, J.; Toro, M. A clinical decision-support system for Dengue based on fuzzy cognitive maps. Health Care Manag. Sci. 2022, 25, 666–681. [Google Scholar] [CrossRef]
  39. Jayashree, L.S.; Lakshmi Devi, R.; Papandrianos, N.; Papageorgiou, E.I. Application of Fuzzy Cognitive Map for geospatial dengue outbreak risk prediction of tropical regions of Southern India. Intell. Decis. Technol. 2018, 12, 231–250. [Google Scholar] [CrossRef]
  40. ODK. Open Data Kit (Version 1.30.1). 2021. Available online: https://opendatakit.org/ (accessed on 22 March 2023).
  41. Canêo, L.F.; Neirotti, R. The Importance of the Proper Definition of Adulthood: What is and What is Not Included in a Scientific Publication. Braz. J. Cardiovasc. Surg. 2017, 32, 60. [Google Scholar] [CrossRef] [Green Version]
  42. Princy, S.; Dhenakaran, S.S. Comparison of triangular and trapezoidal fuzzy membership function. J. Comput. Sci. Eng. 2016, 2, 46–51. [Google Scholar]
  43. Keller, A.; Frey, M.; Schmid, H.; Steffen, R.; Walker, T.; Schlagenhaut, P. Imported Tropical Fever in Switerland, 1993–2004. J. Trop. Med. 2008, 15, 248–251. [Google Scholar]
  44. Goodman, K.W. Ethics, Computing and Medicine: Informatics and the Transformation of Health Care; Cambridge University Press: Cambridge, UK, 1998. [Google Scholar]
  45. Khan, N.; Okoli, C.N.; Ekpin, V.; Attai, K.; Chukwudi, N.; Sabi, H.; Akwaowo, C.; Osuji, J.; Benavente, L.; Uzoka, F.M. Adoption and Utilization of Medical Decision Support Systems in the Diagnosis of Febrile Diseases: A Systematic Literature Review. Expert Syst. Appl. 2023, 220, 119638. [Google Scholar] [CrossRef]
  46. Meredith, R.A.; Arnntt, D.R. On Ethics and Decision Support System Development. In Proceedings of the 7th Pacific Asia Conference on Information System, Adelaide, Australia, 10–13 July 2003; pp. 1–4. [Google Scholar]
  47. Obot, O.; Asuquo, A.; Attai, K.; Johnson, E.; Arnold, K.; Edoho, M.; Ekpenyong, M.; Akwaowo, C.; Udoh, O.; Usen, V.; et al. Development of a mobile app diagnostic system for tropical febrile diseases. In Proceedings of the International Conference on e-Health (EH 2023), Porto, Portugal, 15–17 July 2023. [Google Scholar]
  48. Beauchap, T.L.; Childress, J.F. Principles of Biomedical Ethics, 3rd ed.; Oxford University Press: New York, NY, USA, 1989. [Google Scholar]
Figure 1. Flowchart of the system methodology.
Figure 1. Flowchart of the system methodology.
Tropicalmed 08 00352 g001
Figure 2. Fuzzy Cognitive Map (FCM).
Figure 2. Fuzzy Cognitive Map (FCM).
Tropicalmed 08 00352 g002
Figure 3. System architecture of FCM-based medical DSS for febrile disease diagnosis.
Figure 3. System architecture of FCM-based medical DSS for febrile disease diagnosis.
Tropicalmed 08 00352 g003
Figure 4. FCM performance evaluation.
Figure 4. FCM performance evaluation.
Tropicalmed 08 00352 g004
Table 1. Symptoms rankings for malaria.
Table 1. Symptoms rankings for malaria.
SNMAL
Symptoms
Pearson
Rank
Kendall
Rank
Spearman
Rank
Mean
1BITAIM0.5280.4770.5450.52
2CHLNRIG0.3910.3680.4220.39
3GENBDYPN0.3810.3490.4040.38
4HDACH0.3720.3240.3780.36
5FVR0.3390.3030.3430.33
6HGGDFVR0.3180.2840.3270.31
7MSCBDYPN0.2970.2730.3160.30
8FTG0.2510.2330.2720.25
9SUDONFVR0.2520.2180.2500.24
10LTG0.2450.2180.2520.24
11CTRH0.1940.1880.2150.20
12NUS0.1850.1900.2190.20
13VMT0.1870.1800.2070.19
Table 2. Symptoms Reported by Patient Number Pat_1261.
Table 2. Symptoms Reported by Patient Number Pat_1261.
SymptomDegree of Severity
CTRH0.75
CHSP0.58
CGHDRY0.75
DIFBRT0.58
DRYCGH0.75
FVR0.41
HGPSFVR0.75
HGGDFVR0.75
SWRFVR0.75
SUNDONF0.75
GENBDYP0.58
HDACH0.75
LTG0.58
STRTRT0.75
Table 3. Scenario 1 for Pat_1261 computations for Malaria.
Table 3. Scenario 1 for Pat_1261 computations for Malaria.
Initial Vector0.750.410.750.750.580.750.58Ai(t + 1)Signum Function
Weight0.20000.33000.31000.24000.38000.36000.2400--
1st iteration0.15000.13530.23250.18000.22040.27000.13922.3270.688
2nd iteration0.03000.04460.07210.04320.08380.09720.03341.4040.646
3rd iteration0.00600.01470.02230.01040.03180.03500.00801.1280.630
4th iteration0.00120.00490.00690.00250.01210.01260.00191.0420.625
5th iteration0.00020.00160.00210.00060.00460.00450.00051.0140.623
6th iteration0.00000.00050.00070.00010.00170.00160.00011.0050.623
7th iteration0.00000.00020.00020.00000.00070.00060.00001.0020.623
Table 4. Scenario 2 for Pat_1261 computations for enteric fever.
Table 4. Scenario 2 for Pat_1261 computations for enteric fever.
Initial Vector0.750.750.58Ai(t + 1)Signum Function
Weight0.230.210.17--
1st iteration0.1730.1580.0991.4290.807
2nd iteration0.1290.1180.0571.3050.787
3rd iteration0.0970.0890.0331.2190.772
4th iteration0.0730.0660.0191.1580.761
5th iteration0.0550.0500.0111.1160.753
6th iteration0.0410.0370.0061.0850.747
Table 5. Diagnostic Results for patient number Pat_1261.
Table 5. Diagnostic Results for patient number Pat_1261.
Pat_1261Actual ValueExpert DiagnosisComputed ValueSystem Diagnosis
Malaria0.91Very High0.7888Yes
Enteric Fever0.08No0.701Yes
HIV AID0.08NO0.795No
UPUTI0.08No0.6082No
LWUTI0.08No0.40No
URTI0.91Very High0.892Yes
LRTI0.08No0.9431Yes
TB0.08No0.7501Yes
LASFVR0.08No0.745No
YELFVR0.08No0.6226No
DENFVR0.08No0.7809No
Table 6. Performance Metrics of the classification of 11 diseases.
Table 6. Performance Metrics of the classification of 11 diseases.
DiseaseAccuracyPrecisionRecallF1
Malaria0.7520.7960.8400.817
Enteric Fever0.7180.5070.7650.609
HIV AIDS0.9080.6030.4670.526
UPUTI0.8570.5220.6850.592
LWUTI0.7540.4420.7620.561
URUTI0.8400.7320.2740.399
LRUTI0.8610.5440.6410.589
TB0.7570.2320.8300.363
LASFVR0.9930.2500.0760.118
YELFVR0.9980.50.3330.400
DENFVR0.9890.2720.1500.194
Table 7. Performance measure of the Results.
Table 7. Performance measure of the Results.
DiseaseTPFPFNTNTotal
Malaria13703512614832465
Enteric Fever54352916712262465
HIV/AIDS1268314421122465
UPUTI25623511818562465
LWUTI38748512114722465
URTI1314834719392465
LRTI24520513718782465
TB1705633516972465
LASFVR131224492465
YELFVR11224612465
DENFVR381724372465
Table 8. Results of Diagnosis per Disease.
Table 8. Results of Diagnosis per Disease.
Name of DiseaseNo. of Actual DiagnosesNo. of Predicted Diagnoses
Malaria16311721
Enteric Fever7101072
HIV/AIDS270209
UPUTI374491
LWUTI508872
URTI478179
LRTI382450
TB205733
LASFVR1304
YELFVR0201
DENFVR1111
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Obot, O.; John, A.; Udo, I.; Attai, K.; Johnson, E.; Udoh, S.; Nwokoro, C.; Akwaowo, C.; Dan, E.; Umoh, U.; et al. Modelling Differential Diagnosis of Febrile Diseases with Fuzzy Cognitive Map. Trop. Med. Infect. Dis. 2023, 8, 352. https://doi.org/10.3390/tropicalmed8070352

AMA Style

Obot O, John A, Udo I, Attai K, Johnson E, Udoh S, Nwokoro C, Akwaowo C, Dan E, Umoh U, et al. Modelling Differential Diagnosis of Febrile Diseases with Fuzzy Cognitive Map. Tropical Medicine and Infectious Disease. 2023; 8(7):352. https://doi.org/10.3390/tropicalmed8070352

Chicago/Turabian Style

Obot, Okure, Anietie John, Iberedem Udo, Kingsley Attai, Ekemini Johnson, Samuel Udoh, Chukwudi Nwokoro, Christie Akwaowo, Emem Dan, Uduak Umoh, and et al. 2023. "Modelling Differential Diagnosis of Febrile Diseases with Fuzzy Cognitive Map" Tropical Medicine and Infectious Disease 8, no. 7: 352. https://doi.org/10.3390/tropicalmed8070352

APA Style

Obot, O., John, A., Udo, I., Attai, K., Johnson, E., Udoh, S., Nwokoro, C., Akwaowo, C., Dan, E., Umoh, U., & Uzoka, F. -M. (2023). Modelling Differential Diagnosis of Febrile Diseases with Fuzzy Cognitive Map. Tropical Medicine and Infectious Disease, 8(7), 352. https://doi.org/10.3390/tropicalmed8070352

Article Metrics

Back to TopTop